2022

On January 1, 2021, the Centers for Medicare and Medicaid Services (CMS) implemented a hospital price transparency regulation that…

In late January 2022, JAMA Network Open published an original investigation, “Cost-effectiveness and Economic Benefit of…

In September 2021, the United States Food and Drug Administration (FDA) issued a draft guidance, “Real-Word Data: Assessing…

Atopic dermatitis (AD) is a chronic, relapsing inflammatory condition that is estimated to afflict more than 26 million people in…

In January 2022, the Congressional Budget Office (CBO) released a new report on prescription drugs, with a focus on nationwide…

On February 1, 2022, the United States Department of Justice (DOJ) announced the second-largest amount of False Claims Act…

On January 19, 2022, the United States Food and Drug Administration (FDA) Office of Prescription Drug Promotion (OPDP) sent an…

Earlier this year, the United States Department of Health and Human Services (HHS) Office of the National Coordinator for Health…

In early February 2022, the Centers for Medicare and Medicaid Services (CMS) released its proposed payment policy changes for…

In an effort to educate clinicians and patients on the potential side effects of using Mycophenolate’s during pregnancy, …